Skip to content
drillr.ai
Sign up
ResearchNEU

[NEU] NewMarket Corporation Thesis 2026: Petroleum Additives Cash Engine Plus the AMPAC Rocket-Oxidizer Bet

Ddrillr ResearchOriginal research
Published 18 min read

NewMarket Corporation (NYSE: NEU) is a US specialty-chemicals holding company headquartered in Richmond, Virginia, formed in 2004 from the Ethyl/Albemarle/Afton lineage as the parent of Afton Chemical (petroleum additives) and Ethyl Corporation (a small legacy/services business), and in 2024 it acquired AMPAC (American Pacific Corporation), creating a new Specialty Materials segment. NEU enters FY2026 with FY2025 revenue ~$2.7-3.1B (~flat to +6% YoY off ~$2.78B FY2024) and adj. EPS ~$28-36, reflecting ~$2.5-2.8B aggregate Petroleum Additives revenue plus ~$0.15-0.30B aggregate Specialty Materials (AMPAC) revenue plus a small Ethyl Corp contribution, all under President + CEO Thomas E. Gottwald (CEO since ~2004, ~20+ year tenure; the Gottwald family — a multi-generational industrial family, Ethyl/Albemarle lineage — holds controlling/closely-held ownership; he is the architect of the disciplined high-return petroleum-additives focus, the steady-capital-return model and the AMPAC diversification). The first thesis pillar is the Afton Chemical Petroleum Additives pipeline (~$2.5-2.8B revenue, ~85-92% revenue mix): lubricant additives — engine oil additives (the largest category — packages for passenger-car, heavy-duty and marine engine oils), driveline additives (transmission fluids, gear oils, axle fluids) and industrial-lubricant additives (hydraulic fluids, greases, metalworking, turbine oils) — plus fuel additives (gasoline and diesel detergents, cetane improvers, deposit-control, cold-flow); the petroleum-additives market is ~$15-18B+ globally and a tight oligopoly where ~4 players (Lubrizol/Berkshire, Infineum/ExxonMobil-Shell JV, Afton/NewMarket as the #3-4, Chevron Oronite/Chevron) control most of it, protected by high barriers — long OEM/engine-builder approval cycles, deep R&D and sticky customer specs — with customers the major oil companies, national oil companies and independent blenders, and the business carries high returns on capital, low capital intensity and strong free cash flow; FY2025 dynamics were flat-to-modest volume with raw-material costs (base oils, intermediates) normalizing as a margin tailwind after 2022-2024 inflation and oligopoly pricing discipline holding price/mix, lifting Afton's adj. operating margin toward ~14-18%+, and FY2026 catalyst is ~$2.5-2.9B revenue with continued raw-material relief, pricing discipline, the EV e-fluids/thermal-management opportunity (a small but growing offset to the slow secular EV headwind on engine-oil volumes) and margin toward ~15-19%+. The second pillar is the AMPAC Ammonium Perchlorate + Specialty Chemicals pipeline (~$0.15-0.30B revenue, ~5-10% revenue mix and growing): AMPAC is essentially the only North American producer at scale of ammonium perchlorate (AP) — the oxidizer in solid rocket-motor propellant (the Cedar City, Utah plant) — a true sole-source, strategic-asset franchise essential to US tactical and strategic missiles, missile-defense interceptors and solid-rocket-boosted launch, with effectively no domestic alternative; customers are the prime defense contractors and propulsion houses (Northrop Grumman, L3Harris/Aerojet Rocketdyne) and NASA, plus other specialty chemicals (sodium azide for airbag inflators, perchlorate derivatives, fine chemicals); the defense-spending, missile-replenishment, missile-defense and hypersonics tailwind has surged US and allied demand for tactical missiles (Javelin, Stinger, GMLRS, PAC-3, SM-3/6, NASAMS and more), every solid rocket motor needs AP, and AMPAC is capacity-constrained with multi-year backlogs and higher margins (~25-40%+); FY2025 brought the acquisition close and integration, strong (sold-out) demand, capacity-expansion/debottlenecking capex and long-term supply agreements, and FY2026 catalyst is ~$0.20-0.40B+ revenue on capacity ramp plus supply-agreement price resets materially higher plus hypersonics and next-gen-missile programs, with EBITDA growth and a potential sum-of-the-parts re-rating. The capital story: a ~$10.20-12.00 aggregate annual dividend per share (~1.7-2.5% yield; quarterly ~$2.55+ plus periodic special dividends historically; ~25-35% payout — low, with the rest going to buybacks and M&A), consistent buybacks (~$0.1-0.4B annual — the per-share-compounding lever, with a large share of the float retired over time), ~$0.5-1.5B net debt (modest; the 2024 AMPAC deal added some, deleveraging rapidly on free cash flow), ~0.5-1.5x net debt/EBITDA (low leverage), an investment-grade-equivalent credit profile and ~9-10M diluted shares (very low — the Gottwald family controls a large block; declining on buybacks). At ~$500-700 per share on ~9-10M shares (~$5-7B equity, ~$6-8B EV) NEU trades at ~13-20x P/E, ~9-14x EV/EBITDA and ~2-3x P/Sales versus specialty-chemicals comps Innospec, Croda, Element Solutions, Quaker Houghton, Stepan and Balchem and defense-materials/moat-business comps Cadre Holdings, Mercury Systems, Heico and TransDigm. FY2026 base case is ~$2.7-3.1B revenue + ~$30-40 adj. EPS + ~$0.6-0.85B adj. EBITDA + ~0.5-1.0x net debt/EBITDA; bull case ~$2.9-3.4B revenue + ~$38-50 adj. EPS on Afton raw-material normalization and pricing discipline plus EV e-fluids, AMPAC capacity expansion completing with supply-agreement price resets meaningfully higher amid the missile-replenishment/missile-defense/hypersonics surge (AMPAC revenue toward ~$0.4-0.6B+ at ~30-40%+ margin) plus a sum-of-the-parts re-rating, buybacks and a delevered balance sheet; bear case ~$2.6-2.8B revenue + ~$24-32 adj. EPS on oligopoly pricing breaking down, a faster-than-expected EV headwind, a raw-material-cost spike, weak global industrial activity, AMPAC capacity-expansion delays or a defense-budget downturn, AMPAC safety/environmental/regulatory incidents, customer-concentration risk and Gottwald-family-control/minority considerations. The thesis depends on the Afton Chemical Petroleum Additives pipeline plus the AMPAC Ammonium Perchlorate + Specialty Chemicals pipeline plus the global petroleum-additives oligopoly position plus sticky OEM-approved specs plus raw-material-cost normalization plus the sole-source North American ammonium-perchlorate franchise plus the defense/missile tailwind plus capacity expansion plus the low dividend payout plus consistent buybacks plus the low share count plus low leverage and Thomas Gottwald's disciplined-capital-return and AMPAC-integration execution.

[NEU] NewMarket Corporation Thesis 2026: Petroleum Additives Cash Engine Plus the AMPAC Rocket-Oxidizer Bet

Key Takeaways

  • NEU FY2025 revenue ~$2.7-3.1B (~flat to +6% YoY) with adj. EPS ~$28-36 reflecting continued ~$2.5-2.8B aggregate Petroleum Additives (Afton Chemical) revenue + ~$0.15-0.30B aggregate Specialty Materials (AMPAC — ammonium perchlorate / specialty chemicals) revenue + selected various aggregate ~Ethyl Corporation (services/legacy) revenue under continued President + CEO Thomas E. Gottwald (~~~~20+ year tenure as NewMarket CEO since ~~2004; selected primary post-2004 leadership + selected various aggregate ~~the Gottwald family — controlling/closely-held ownership across multiple generations (Ethyl/Albemarle/NewMarket lineage) + selected primary architect of post-2004-2025 ~~the disciplined, high-return petroleum-additives focus + the steady-capital-return model + the 2024 AMPAC acquisition (a diversification into ammonium perchlorate / defense-aerospace specialty chemicals)).
  • Afton Chemical Petroleum Additives Pipeline (~$2.5-2.8B Revenue): ~$2.5-2.8B aggregate Petroleum Additives revenue (aggregate ~85-92% revenue mix); selected primary Afton Chemical (selected primary ~~lubricant additives — engine oil additives (the largest category — additive packages for passenger-car + heavy-duty + marine engine oils, the chemistry that lets oil protect + clean + last) + driveline additives (transmission fluids, gear oils, axle fluids) + industrial-lubricant additives (hydraulic fluids, greases, metalworking, turbine oils) + fuel additives (gasoline + diesel detergents, cetane improvers, deposit-control, cold-flow) + selected various aggregate ~~~a global oligopoly (~~4 players control most of the ~~$15-18B+ petroleum-additives market — Lubrizol (Berkshire Hathaway), Infineum (ExxonMobil-Shell JV), Afton (NewMarket), Chevron Oronite (Chevron) — high barriers: long OEM/engine-builder approval cycles, deep R&D, sticky customer specs + selected various aggregate ~~~Afton is ~~the #3-4 player + selected various aggregate ~~~~customers — the major oil companies (Shell, ExxonMobil, BP, Chevron, TotalEnergies) + national oil companies + independent lubricant blenders + selected various aggregate ~~~~~~high returns on capital, low capital intensity, strong free cash flow) + selected various aggregate post-2024-2025 ~Afton demand + margin (selected primary ~~~~lubricant-demand fundamentals — global vehicle parc + miles driven + industrial activity (relatively stable, GDP-ish, with a slow secular EV headwind to engine-oil volumes offset by higher additive content in modern oils + EV-specific fluids — e-fluids/thermal-management/driveline for EVs are a new opportunity) + selected various aggregate ~~~~raw-material costs (base oils, intermediates) normalizing — a margin tailwind after 2022-2024 inflation + selected various aggregate ~~~~pricing discipline (the oligopoly passes through costs) + selected various aggregate ~~~~~~~~~~~~~Afton adj. operating margin toward ~~~14-18%+ aggregate).
  • AMPAC Ammonium Perchlorate + Specialty Chemicals Pipeline (~$0.15-0.30B Revenue + Defense-Aerospace Catalyst): ~$0.15-0.30B aggregate Specialty Materials (AMPAC) revenue (aggregate ~5-10% revenue mix, growing); selected primary AMPAC / American Pacific Corporation (selected primary ~~~~ammonium perchlorate (AP) — the oxidizer in solid rocket-motor propellant — AMPAC is essentially the only North American producer at scale (the Cedar City, Utah plant) + selected various aggregate ~~~~the customer base — the prime defense contractors + propulsion houses (Northrop Grumman (NOC) — solid rocket motors for missiles + space launch, Aerojet Rocketdyne (now L3Harris — LHX), and others) + NASA + selected various aggregate ~~~~a true sole-source / strategic-asset franchise — AP is essential to US missiles (tactical + strategic), missile defense (interceptors), and solid-rocket-boosted launch — and there is effectively no domestic alternative + selected various aggregate ~~~~plus other specialty chemicals — sodium azide (airbag inflators), perchlorate derivatives, fine chemicals + selected various aggregate ~~~~the defense-spending / missile-replenishment / hypersonics / missile-defense tailwind — US + allied demand for tactical missiles (Javelin, Stinger, GMLRS, PAC-3, SM-3/6, etc.) has surged, and every solid rocket motor needs AP + selected various aggregate ~~~~higher-margin than petroleum additives, capacity-constrained, multi-year backlogs, the new growth leg for NewMarket) + selected various aggregate post-2024-2025 ~AMPAC integration + capacity (selected primary ~~~~the 2024 acquisition close + integration + selected various aggregate ~~~~capacity-expansion / debottlenecking capex (AP demand exceeds current supply — investing to expand) + selected various aggregate ~~~~long-term-supply-agreement renewals at higher prices + selected various aggregate ~~~~~~~~AMPAC revenue + EBITDA growth as defense demand + capacity ramp).
  • Capital position + balance sheet: ~$10.20-12.00 aggregate annual dividend per share (~~~~1.7-2.5% aggregate yield; selected primary ~~~~quarterly ~~~$2.55+ + selected various aggregate ~~~periodic special dividends historically + selected various aggregate ~~~~~~~~~~~25-35% payout — low; the rest goes to buybacks + M&A) + selected various aggregate ~$0.1-0.4B aggregate annual buybacks (selected primary ~~~consistent share-count reduction over time — NewMarket has bought back a large % of its shares) + aggregate net debt ~$0.5-1.5B (selected various aggregate ~~~~modest; the AMPAC acquisition added some debt; rapid deleveraging on free cash flow) + selected primary ~~~~~0.5-1.5x aggregate net debt / EBITDA (low leverage) + investment-grade-equivalent credit profile (selected various aggregate ~~~conservatively managed; not aggressively rated-driven) + ~~~~~~9-10M aggregate diluted shares (selected various aggregate ~~~very low share count — Gottwald family controls a large block; declining on buybacks).
  • FY2026 thesis catalysts: Afton Chemical Petroleum Additives pipeline (~$2.5-2.8B + engine oil + driveline + industrial + fuel additives + the global oligopoly position + sticky OEM-approved specs + raw-material-cost normalization margin tailwind + pricing discipline + EV e-fluids opportunity + 14-18%+ adj. operating margin) + AMPAC Ammonium Perchlorate + Specialty Chemicals pipeline ($0.15-0.30B + sole-source North American ammonium perchlorate + defense/missile-replenishment/missile-defense/hypersonics tailwind + capacity expansion + higher-priced supply agreements + Northrop/L3Harris/NASA customers + the new high-margin growth leg) + ~$10.20-12.00 dividend + consistent buybacks + ~0.5-1.5x net debt/EBITDA + Thomas Gottwald disciplined-capital-return + AMPAC integration execution.

Company Background

NewMarket Corporation (NYSE: NEU) is a US specialty-chemicals holding company headquartered in Richmond, Virginia, with roots to the Ethyl/Albemarle/Afton lineage (selected primary post-2004 ~~~NewMarket formed as the holding company for Afton Chemical (petroleum additives) + Ethyl Corporation (services/legacy) — spun out of the Ethyl/Albemarle family of companies (the Gottwald family's long industrial history — Ethyl Corp, Albemarle, etc.) + selected post-2004-2025 ~~~the disciplined petroleum-additives focus + steady capital return + selected post-2023-2024 ~~~the AMPAC (American Pacific Corporation) acquisition — a diversification into ammonium perchlorate / defense-aerospace specialty chemicals + the new "Specialty Materials" segment + selected various aggregate ~~~NYSE listing). Selected ~NYSE listing as NewMarket; selected post-2004-2025 Thomas E. Gottwald CEO era (~20+ year tenure; the Gottwald family — controlling/closely-held ownership; architect of the high-return petroleum-additives focus + the AMPAC diversification); HQ Richmond, Virginia; ~~~2,000-2,500 employees.

NEU operates two segments: Petroleum Additives (~85-92% revenue mix; ~$2.5-2.8B; Afton Chemical — lubricant additives (engine oil, driveline, industrial) + fuel additives (gasoline + diesel); a global oligopoly with Lubrizol/Berkshire, Infineum/ExxonMobil-Shell, Chevron Oronite; ~the #3-4 player) + Specialty Materials (~5-10% revenue mix, growing; ~$0.15-0.30B; AMPAC — ammonium perchlorate (solid-rocket-motor oxidizer; ~the only North American producer at scale) + sodium azide, perchlorate derivatives, fine chemicals; defense/aerospace customers) + Ethyl Corporation (a small legacy/services business). Geographic mix (petroleum additives): North America ~35-40% + Asia Pacific ~25-30% + Europe ~20-25% + Latin America/other ~10-15%. Capital position: ~$10.20-12.00 aggregate annual dividend per share (~1.7-2.5% yield) + ~$0.1-0.4B aggregate annual buybacks + aggregate net debt ~$0.5-1.5B + ~0.5-1.5x aggregate net debt/EBITDA + investment-grade-equivalent credit profile + ~9-10M aggregate diluted shares (very low; Gottwald family controls a large block).

Afton Chemical Petroleum Additives Pipeline (~$2.5-2.8B Revenue)

The Afton Chemical Petroleum Additives pipeline is NEU's foundation thesis: ~$2.5-2.8B aggregate Petroleum Additives revenue (aggregate ~85-92% revenue mix); selected primary Afton Chemical (selected primary ~~lubricant additives — engine oil additives (the largest category — additive packages for passenger-car + heavy-duty + marine engine oils) + driveline additives (transmission fluids, gear oils, axle fluids) + industrial-lubricant additives (hydraulic fluids, greases, metalworking, turbine oils) + fuel additives (gasoline + diesel detergents, cetane improvers, deposit-control, cold-flow) + selected various aggregate ~~~a global oligopoly (~~4 players control most of the ~~$15-18B+ petroleum-additives market — Lubrizol (Berkshire Hathaway), Infineum (ExxonMobil-Shell JV), Afton (NewMarket), Chevron Oronite (Chevron) — high barriers: long OEM/engine-builder approval cycles, deep R&D, sticky customer specs + selected various aggregate ~~~Afton is ~~the #3-4 player + selected various aggregate ~~~~customers — the major oil companies + national oil companies + independent lubricant blenders + selected various aggregate ~~~~~~high returns on capital, low capital intensity, strong free cash flow) + selected various aggregate post-2024-2025 ~Afton demand + margin.

FY2025 Afton Chemical Petroleum Additives dynamics ($2.5-2.8B aggregate revenue): selected continued ~flat-to-modest aggregate Petroleum Additives revenue (selected primary ~~~~lubricant-demand fundamentals — global vehicle parc + miles driven + industrial activity (relatively stable, GDP-ish, with a slow secular EV headwind to engine-oil volumes partly offset by higher additive content in modern low-viscosity oils + selected various aggregate ~~~~EV-specific fluids — e-fluids/thermal-management/driveline for EVs — a new opportunity) + selected various aggregate ~~~~raw-material costs (base oils, intermediates) normalizing — a margin tailwind after 2022-2024 inflation + selected various aggregate ~~~~pricing discipline (the oligopoly passes costs through; price/mix held) + selected various aggregate ~~~~volume roughly flat-to-up low-single-digit %) + ~$2.5-2.8B aggregate Petroleum Additives revenue + selected various aggregate ~~~~Afton adj. operating margin toward ~~~14-18%+ aggregate (selected various aggregate ~~recovering on raw-material relief + pricing). Selected post-2024 ~$24-32 aggregate annual adj. EPS contribution as the Afton Chemical Petroleum Additives pipeline drives the dominant cash-engine earnings base.

FY2026 catalyst: continued Afton Chemical Petroleum Additives pipeline + ~$24-32 aggregate adj. EPS contribution under continued Thomas Gottwald leadership (~20+ year tenure). Selected aggregate ~$2.5-2.9B aggregate FY2026 Petroleum Additives revenue + selected various ~~~~flat-to-low-single-digit % aggregate volume + selected various aggregate ~~~~raw-material-cost normalization (margin tailwind) + selected various aggregate ~~~~pricing/mix discipline + selected various aggregate ~~~~the EV e-fluids/thermal-management opportunity (a small but growing offset to the engine-oil-volume EV headwind) + selected various aggregate ~~~~Afton adj. operating margin toward ~~~15-19%+ aggregate (continued recovery + operating leverage). Risks: Lubrizol (within Berkshire Hathaway — BRK.B; the #1 petroleum-additives player) + Infineum (the ExxonMobil-Shell JV; the #2) + Chevron Oronite (within Chevron — CVX; #4) + (these three are the entire competitive set — it's a tight oligopoly) + on adjacent specialty chemicals: BASF, Evonik, Croda, Innospec (IOSP — fuel additives), Clariant + selected various aggregate petroleum-additives competitive considerations + the EV-transition secular headwind (long-term — fewer internal-combustion engines means fewer engine-oil changes; though heavy-duty/off-road/marine/industrial/aviation lag, additive content per liter rises, and EV-specific fluids are an offset) + raw-material-cost cycle considerations (base oils — tied to crude/refining; intermediates) + global-industrial-activity / GDP considerations (industrial lubricants + fuel additives are macro-sensitive) + customer-concentration considerations (the major oil companies) + OEM-spec / approval-cycle considerations (a moat — but also a barrier to gaining share) + China / national-oil-company competitive considerations (slow Chinese-additive-maker capability build) + pricing-discipline considerations (the oligopoly's pricing power depends on no one breaking ranks).

AMPAC Ammonium Perchlorate + Specialty Chemicals Pipeline (~$0.15-0.30B Revenue + Defense-Aerospace Catalyst)

The AMPAC Ammonium Perchlorate + Specialty Chemicals pipeline is NEU's primary new-growth-leg thesis: ~$0.15-0.30B aggregate Specialty Materials (AMPAC) revenue (aggregate ~5-10% revenue mix, growing); selected primary AMPAC / American Pacific Corporation (selected primary ~~~~ammonium perchlorate (AP) — the oxidizer in solid rocket-motor propellant — AMPAC is essentially the only North American producer at scale (the Cedar City, Utah plant) + selected various aggregate ~~~~the customer base — the prime defense contractors + propulsion houses (Northrop Grumman (NOC) — solid rocket motors for missiles + space launch; Aerojet Rocketdyne (now within L3Harris — LHX); and others) + NASA + selected various aggregate ~~~~a true sole-source / strategic-asset franchise — AP is essential to US tactical + strategic missiles, missile-defense interceptors, and solid-rocket-boosted launch — with effectively no domestic alternative (a national-security supply line) + selected various aggregate ~~~~plus other specialty chemicals — sodium azide (airbag inflators), perchlorate derivatives, fine chemicals + selected various aggregate ~~~~the defense-spending / missile-replenishment / hypersonics / missile-defense tailwind — US + allied demand for tactical missiles (Javelin, Stinger, GMLRS, PAC-3, SM-3/6, NASAMS, etc.) has surged post-Ukraine/Middle East, and every solid rocket motor needs AP + selected various aggregate ~~~~higher-margin than petroleum additives, capacity-constrained, multi-year backlogs) + selected various aggregate post-2024-2025 ~AMPAC integration + capacity.

FY2025 AMPAC dynamics: selected primary ~~~~the 2024 acquisition close + integration into NewMarket (the new "Specialty Materials" segment) + selected various aggregate ~~~~~$0.15-0.30B aggregate AMPAC revenue + selected various aggregate ~~~~strong demand (the missile-replenishment + missile-defense surge — AMPAC is sold out / capacity-constrained) + selected various aggregate ~~~~capacity-expansion / debottlenecking capex (investing to expand AP output — demand exceeds current supply) + selected various aggregate ~~~~long-term supply agreements with the primes + selected various aggregate ~~~~~~~higher AMPAC adj. operating / EBITDA margin (selected various aggregate ~~~~~25-40%+ — a much higher-margin business than petroleum additives, given the sole-source position). Selected post-2024 ~$2.00-4.00+ aggregate annual adj. EPS contribution (selected various aggregate ~~growing as capacity ramps + prices reset) as the AMPAC pipeline drives the new defense-aerospace growth leg.

FY2026 catalyst: continued AMPAC pipeline + ~$2.00-4.00+ aggregate adj. EPS contribution + selected various aggregate ~~~~~$0.20-0.40B+ aggregate FY2026 AMPAC revenue (selected various aggregate ~~growing on capacity ramp + price resets + defense demand) + selected various aggregate ~~~~capacity-expansion capex (debottlenecking + new AP capacity coming online — the binding constraint is supply) + selected various aggregate ~~~~long-term-supply-agreement renewals at materially higher prices (AMPAC has pricing power as the sole source + a captive defense customer base) + selected various aggregate ~~~~hypersonics + next-gen-missile programs (LRSO, SiAW, GMLRS-ER, NGI, etc. — more solid rocket motors = more AP) + selected various aggregate ~~~~~~~~AMPAC EBITDA growth + a re-rating contribution (a sole-source defense-strategic-asset business deserves a higher multiple than a chemicals additive business). Risks: there are no direct AP competitors in North America (that's the moat) — but: defense-budget / appropriations considerations (AP demand is ultimately a function of missile-procurement budgets — a defense-spending downturn or program cancellations would hurt; though missile-replenishment is a bipartisan priority) + capacity-expansion-execution considerations (expanding a hazardous-chemicals plant is slow, capital-intensive, and permitting-heavy; delays cap the growth) + safety / environmental / regulatory considerations (AP is a hazardous material; the Cedar City plant has had historical incidents in the industry; perchlorate is an environmental contaminant — regulatory/remediation exposure) + customer-concentration considerations (Northrop Grumman + L3Harris/Aerojet are the dominant customers — sole-source on both sides) + the prime contractors' solid-rocket-motor supply situation (Northrop and L3Harris/Aerojet are the two domestic SRM makers; their capacity + program wins drive AP demand) + a potential new domestic AP entrant (unlikely given the barriers, but defense-industrial-base policy could fund one) + pricing-vs-customer-relationship considerations (AMPAC can raise prices, but it doesn't want to be seen gouging a national-security customer) + integration considerations (AMPAC is culturally + operationally different from petroleum additives) + the small-base / lumpiness considerations.

Capital Position + Balance Sheet

Capital position + balance sheet: ~$10.20-12.00 aggregate annual dividend per share (~~~~1.7-2.5% aggregate yield; selected primary ~~~~quarterly ~~~$2.55+ + selected various aggregate ~~~periodic special dividends historically — NewMarket has paid large specials when cash builds + selected various aggregate ~~~~~~~~~~~25-35% payout — low; the rest goes to buybacks + M&A) + selected various aggregate ~$0.1-0.4B aggregate annual buybacks (selected primary ~~~consistent share-count reduction over time — NewMarket has bought back a large % of its shares, a key part of the per-share compounding) + aggregate net debt ~$0.5-1.5B (selected various aggregate ~~~~modest; the 2024 AMPAC acquisition added some debt; the company deleverages rapidly on its strong free cash flow) + selected primary ~~~~~0.5-1.5x aggregate net debt / EBITDA (low leverage; the AMPAC bump declining quickly) + investment-grade-equivalent credit profile (selected various aggregate ~~~conservatively managed; the Gottwald family runs it for the long term) + ~~~~~~9-10M aggregate diluted shares (selected various aggregate ~~~very low share count — the Gottwald family controls a large block; declining on buybacks) + selected various aggregate ~~~~~$0.3-0.6B aggregate liquidity (revolver + cash).

FY2026 catalyst: continued dividend (~$10.20-12.00 aggregate annual; selected various aggregate ~~~mid-single-digit % aggregate dividend growth + selected various aggregate ~~~potential special dividend if cash builds) + selected continued ~$0.1-0.4B aggregate annual buybacks (selected primary ~~~the per-share compounding lever — fewer shares each year) + selected various aggregate ~~~~~0.5-1.0x aggregate net debt/EBITDA (selected primary ~~~rapid deleveraging post-AMPAC on free cash flow + selected various aggregate ~~~capacity for another acquisition once delevered) + selected various aggregate ~~~~AMPAC capacity-expansion capex (a use of cash, but high-return) + selected various aggregate ~~~~modest/selective M&A optionality (NewMarket is patient — AMPAC was the first big move in years; another could come) + selected continued investment-grade-equivalent credit profile. Selected dividend (+ specials) + selected consistent buybacks + selected ~low leverage + selected ~strong free cash flow support the cash-engine-funds-buybacks-and-defense-growth-leg model.

Key Core Metrics

  • FY2025 revenue ~$2.7-3.1B (~flat to +6% YoY) vs ~$2.78B FY2024; adj. EPS ~$28-36
  • 2 segments: Petroleum Additives ~85-92% ($2.5-2.8B; Afton Chemical — lubricant additives (engine oil, driveline, industrial) + fuel additives; a global oligopoly with Lubrizol/Berkshire, Infineum/ExxonMobil-Shell, Chevron Oronite; ~#3-4 player) + Specialty Materials ~5-10%, growing ($0.15-0.30B; AMPAC — ammonium perchlorate (solid-rocket-motor oxidizer; ~the only North American producer at scale) + sodium azide + perchlorate derivatives + fine chemicals; defense/aerospace) + Ethyl Corp (small legacy/services)
  • Afton adj. operating margin: toward ~14-18%+ aggregate FY2025 (recovering on raw-material relief + pricing)
  • AMPAC adj. operating/EBITDA margin: ~25-40%+ (much higher-margin than petroleum additives; sole-source position)
  • Petroleum-additives market: ~$15-18B+ global; ~4 players control most of it (Lubrizol, Infineum, Afton, Chevron Oronite); high barriers (long OEM approval cycles, deep R&D, sticky specs)
  • AMPAC: the only North American producer of ammonium perchlorate at scale (Cedar City, Utah); customers Northrop Grumman (NOC), L3Harris/Aerojet (LHX), NASA; defense/missile-replenishment/missile-defense/hypersonics tailwind; capacity-constrained, multi-year backlogs
  • Aggregate adj. EBITDA: ~$0.6-0.8B FY2025
  • Returns: high return on capital, low capital intensity, strong free cash flow (a key part of the long-run story)
  • Aggregate net debt: ~$0.5-1.5B (modest; AMPAC acquisition added some, deleveraging rapidly); ~0.5-1.5x aggregate net debt/EBITDA (low leverage)
  • Investment-grade-equivalent credit profile (conservatively managed)
  • ~9-10M aggregate diluted shares (very low — Gottwald family controls a large block; declining on buybacks); ~$0.1B total dividends FY2025
  • Dividend: ~$10.20-12.00 aggregate annual per share (~1.7-2.5% yield; quarterly ~$2.55+; periodic special dividends historically; ~25-35% payout — low)
  • Consistent buybacks (~$0.1-0.4B aggregate annual — the per-share compounding lever)
  • Geographic mix (petroleum additives): North America ~35-40% + Asia Pacific ~25-30% + Europe ~20-25% + Latin America/other ~10-15%
  • ~$0.3-0.6B aggregate liquidity (revolver + cash)
  • ~2,000-2,500 employees
  • Thomas E. Gottwald President + CEO since ~2004 (~20+ year tenure); the Gottwald family — controlling/closely-held ownership
  • HQ Richmond, Virginia; NewMarket formed 2004 (from the Ethyl/Albemarle/Afton lineage); NYSE listing; AMPAC acquired 2024

Market Evaluation

NEU FY2026 market evaluation: at ~$500-700 share price + ~9-10M aggregate diluted shares = ~$5-7B equity market cap; ~$6-8B aggregate enterprise value (incl. ~$0.5-1.5B net debt); ~$10.20-12.00 aggregate annual dividend (~1.7-2.5% aggregate yield). Selected primary NEU peers: Innospec (IOSP, ~$2-3B Mcap; specialty chemicals incl. fuel additives — a partial petroleum-additives comp) + Lubrizol (within Berkshire Hathaway — not separately traded; the #1 petroleum-additives player) + Chevron Oronite (within Chevron — CVX) + Infineum (the ExxonMobil-Shell JV — not traded) + on the broader specialty-chemicals lens: Croda (UK), Element Solutions (ESI, ~$5-7B), Quaker Houghton (KWR, ~$2-3B; metalworking fluids), Stepan (SCL), Balchem (BCPC) + on the AMPAC/defense-materials lens: Cadre Holdings (CDRE), Mercury Systems (MRCY), Ducommun (DCO), Triumph Group (TGI), Heico (HEI), TransDigm (TDG; sole-source aerospace components — a "moat business" valuation comp) + selected various aggregate specialty-chemicals + defense-aerospace companies. Selected NEU ~13-20x P/E (a high-return, low-capital-intensity petroleum-additives cash engine — Afton, ~#3-4 in a global oligopoly with sticky OEM-approved specs — plus AMPAC, the sole-source North American ammonium-perchlorate producer riding a multi-year defense/missile tailwind; with a low dividend payout, consistent buybacks, low leverage, a very low share count, and Gottwald-family long-term control) + selected ~~~9-14x EV/EBITDA + selected ~~~2-3x P/Sales + ~1.7-2.5% dividend yield + selected aggregate ~$2.7-3.1B aggregate FY2026 revenue + selected aggregate ~$30-40 aggregate FY2026 adj. EPS + selected aggregate Afton Chemical Petroleum Additives + AMPAC Specialty Chemicals pipeline + sum-of-the-parts (a steady high-ROC additives business + a fast-growing sole-source defense-strategic-asset business that deserves a defense/moat-business multiple). FY2026 base case: ~$2.7-3.1B aggregate revenue + ~$30-40 adj. EPS + ~$0.6-0.85B adj. EBITDA + ~0.5-1.0x net debt/EBITDA. Bull case: Afton Chemical Petroleum Additives pipeline acceleration (raw-material-cost normalization + pricing/mix discipline + EV e-fluids opportunity + ~16-19%+ Afton adj. operating margin) + AMPAC pipeline acceleration (capacity expansion completing + supply-agreement price resets meaningfully higher + the missile-replenishment/missile-defense/hypersonics surge + AMPAC revenue toward $0.4-0.6B+ at ~30-40%+ margin + a sum-of-the-parts re-rating as the market values AMPAC like a sole-source defense asset) + buybacks (declining share count) + a delevered balance sheet (M&A optionality) drives ~$2.9-3.4B aggregate revenue + ~$38-50 adj. EPS + multiple expansion. Bear case: Lubrizol + Infineum + Chevron Oronite competitive intensification or a break in oligopoly pricing discipline + the EV-transition secular headwind to engine-oil volumes (faster than expected) + a raw-material-cost spike (base oils, intermediates) + global-industrial-activity weakness (industrial lubricants + fuel additives) + AMPAC capacity-expansion delays or a defense-budget downturn / program cancellations + AMPAC safety/environmental/regulatory incidents (AP is hazardous; perchlorate is a contaminant) + customer-concentration risk (Northrop, L3Harris/Aerojet on AMPAC; the major oil companies on Afton) + Gottwald-family-control / minority-shareholder considerations drives ~$2.6-2.8B revenue + ~$24-32 adj. EPS + a de-rating. The thesis depends on the Afton Chemical Petroleum Additives pipeline + the AMPAC Ammonium Perchlorate + Specialty Chemicals pipeline + the global petroleum-additives oligopoly position + sticky OEM-approved specs + raw-material-cost normalization + the sole-source North American ammonium-perchlorate franchise + the defense/missile tailwind + capacity expansion + the low dividend payout + consistent buybacks + the low share count + low leverage + Thomas Gottwald disciplined-capital-return + AMPAC integration execution.

Companies in this article